Report
Lenny Van Steenhuyse ...
  • Ruben Devos
  • Sandra Cauwenberghs
  • Wim Hoste

KBC Securities Morning Note 21-1-2019 ARGX BB, NYR BB

Argenx: Janssen deal on cusatuzumab finalized
Nyrstar: Trafigura strengthens control, CFO leaves
Telecom: Afterthoughts spectrum auction delay
Underlyings
3P Learning

3P Learning is engaged in developing, sales and marketing of online educational program to schools and parents of school-aged students.

ArGEN-X SE

Argenx N.V. is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Utilizing its suite of differentiated technologies, Co. is focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex, targets in order to treat diseases with a significant unmet medical need.

Nyrstar NV

Nyrstar is a multi-metals company, produces and sells zinc and lead, as well as other metals, such as silver, gold, and copper. Co. produces zinc, which is used to protect steel from corrosion to construction and transport sectors. Co.'s products include zinc die casting alloys for hot chamber die casting processes, as well as niche alloys for special purposes to produce everyday objects, such as kitchen and bathroom fittings, toys, lock ware, zippers, and various auto and electronic components; zinc and special zinc alloys for the hot dip galvanizing industry; and zinc-continuous galvanizing products used in the construction, automotive, and consumer goods sectors.

Provider
KBC Securities
KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

 

Analysts
Lenny Van Steenhuyse

Ruben Devos

Sandra Cauwenberghs

Wim Hoste

Other Reports on these Companies
Other Reports from KBC Securities

ResearchPool Subscriptions

Get the most out of your insights

Get in touch